101 related articles for article (PubMed ID: 26759239)
1. Small-Molecule Prodigiosin Restores p53 Tumor Suppressor Activity in Chemoresistant Colorectal Cancer Stem Cells via c-Jun-Mediated ΔNp73 Inhibition and p73 Activation.
Prabhu VV; Hong B; Allen JE; Zhang S; Lulla AR; Dicker DT; El-Deiry WS
Cancer Res; 2016 Apr; 76(7):1989-99. PubMed ID: 26759239
[TBL] [Abstract][Full Text] [Related]
2. Prodigiosin rescues deficient p53 signaling and antitumor effects via upregulating p73 and disrupting its interaction with mutant p53.
Hong B; Prabhu VV; Zhang S; van den Heuvel AP; Dicker DT; Kopelovich L; El-Deiry WS
Cancer Res; 2014 Feb; 74(4):1153-65. PubMed ID: 24247721
[TBL] [Abstract][Full Text] [Related]
3. Evidence that DeltaNp73 promotes neuronal survival by p53-dependent and p53-independent mechanisms.
Lee AF; Ho DK; Zanassi P; Walsh GS; Kaplan DR; Miller FD
J Neurosci; 2004 Oct; 24(41):9174-84. PubMed ID: 15483136
[TBL] [Abstract][Full Text] [Related]
4. Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53.
Zhang S; Zhou L; Hong B; van den Heuvel AP; Prabhu VV; Warfel NA; Kline CL; Dicker DT; Kopelovich L; El-Deiry WS
Cancer Res; 2015 Sep; 75(18):3842-52. PubMed ID: 26294215
[TBL] [Abstract][Full Text] [Related]
5. deltaNp73 facilitates cell immortalization and cooperates with oncogenic Ras in cellular transformation in vivo.
Petrenko O; Zaika A; Moll UM
Mol Cell Biol; 2003 Aug; 23(16):5540-55. PubMed ID: 12897129
[TBL] [Abstract][Full Text] [Related]
6. Characterization of ΔNp73 expression and regulation in gastric and esophageal tumors.
Vilgelm AE; Hong SM; Washington MK; Wei J; Chen H; El-Rifai W; Zaika A
Oncogene; 2010 Oct; 29(43):5861-8. PubMed ID: 20676143
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of NFkappaB-responsive gene expression by DeltaNp73alpha in p53 null cells.
Tanaka Y; Ota K; Kameoka M; Itaya A; Yoshihara K
Exp Cell Res; 2006 May; 312(8):1254-64. PubMed ID: 16430884
[TBL] [Abstract][Full Text] [Related]
8. Small-molecule modulators of p53 family signaling and antitumor effects in p53-deficient human colon tumor xenografts.
Wang W; Kim SH; El-Deiry WS
Proc Natl Acad Sci U S A; 2006 Jul; 103(29):11003-8. PubMed ID: 16835297
[TBL] [Abstract][Full Text] [Related]
9. DeltaNp73 modulates nerve growth factor-mediated neuronal differentiation through repression of TrkA.
Zhang J; Chen X
Mol Cell Biol; 2007 May; 27(10):3868-80. PubMed ID: 17353261
[TBL] [Abstract][Full Text] [Related]
10. A network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cells.
Yu J; Baron V; Mercola D; Mustelin T; Adamson ED
Cell Death Differ; 2007 Mar; 14(3):436-46. PubMed ID: 16990849
[TBL] [Abstract][Full Text] [Related]
11. Expression of the p53 family in lung cancer.
Uramoto H; Sugio K; Oyama T; Nakata S; Ono K; Nozoe T; Yasumoto K
Anticancer Res; 2006; 26(3A):1785-90. PubMed ID: 16827107
[TBL] [Abstract][Full Text] [Related]
12. Small-molecule CB002 restores p53 pathway signaling and represses colorectal cancer cell growth.
Richardson C; Zhang S; Hernandez Borrero LJ; El-Deiry WS
Cell Cycle; 2017 Sep; 16(18):1719-1725. PubMed ID: 28749206
[TBL] [Abstract][Full Text] [Related]
13. HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function.
Lau LM; Nugent JK; Zhao X; Irwin MS
Oncogene; 2008 Feb; 27(7):997-1003. PubMed ID: 17700533
[TBL] [Abstract][Full Text] [Related]
14. TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.
Malaguarnera R; Vella V; Pandini G; Sanfilippo M; Pezzino V; Vigneri R; Frasca F
Mol Cancer Res; 2008 Jan; 6(1):64-77. PubMed ID: 18234963
[TBL] [Abstract][Full Text] [Related]
15. Proinflammatory cytokines and bile acids upregulate ΔNp73 protein, an inhibitor of p53 and p73 tumor suppressors.
Zaika E; Bhardwaj V; Wei J; Washington MK; Souza R; El-Rifai W; Zaika A
PLoS One; 2013; 8(5):e64306. PubMed ID: 23717592
[TBL] [Abstract][Full Text] [Related]
16. p73: From the p53 shadow to a major pharmacological target in anticancer therapy.
Ramos H; Raimundo L; Saraiva L
Pharmacol Res; 2020 Dec; 162():105245. PubMed ID: 33069756
[TBL] [Abstract][Full Text] [Related]
17. p73 in Cancer.
Rufini A; Agostini M; Grespi F; Tomasini R; Sayan BS; Niklison-Chirou MV; Conforti F; Velletri T; Mastino A; Mak TW; Melino G; Knight RA
Genes Cancer; 2011 Apr; 2(4):491-502. PubMed ID: 21779517
[TBL] [Abstract][Full Text] [Related]
18. The combination of 5-fluorouracil plus p53 pathway restoration is associated with depletion of p53-deficient or mutant p53-expressing putative colon cancer stem cells.
Huang C; Zhang XM; Tavaluc RT; Hart LS; Dicker DT; Wang W; El-Deiry WS
Cancer Biol Ther; 2009 Nov; 8(22):2186-93. PubMed ID: 19923910
[TBL] [Abstract][Full Text] [Related]
19. Tumor stem-like cell-derived exosomal RNAs prime neutrophils for facilitating tumorigenesis of colon cancer.
Hwang WL; Lan HY; Cheng WC; Huang SC; Yang MH
J Hematol Oncol; 2019 Jan; 12(1):10. PubMed ID: 30683126
[TBL] [Abstract][Full Text] [Related]
20. Adenylate kinase hCINAP determines self-renewal of colorectal cancer stem cells by facilitating LDHA phosphorylation.
Ji Y; Yang C; Tang Z; Yang Y; Tian Y; Yao H; Zhu X; Zhang Z; Ji J; Zheng X
Nat Commun; 2017 May; 8():15308. PubMed ID: 28516914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
